Open AccessKetamine for Sickle Cell Vaso-Occlusive Crises: A Systematic Review
Author(s) -
Mohammed Alshahrani,
Mohannad Alghamdi
Publication year - 2021
Publication title -
saudi journal of medicine and medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 2
eISSN - 1658-631X
pISSN - 2321-4856
DOI - 10.4103/sjmms.sjmms_218_20
Subject(s) - ketamine , medicine , cochrane library , adverse effect , opioid , incidence (geometry) , randomized controlled trial , vaso occlusive crisis , anesthesia , analgesic , morphine , sickle cell anemia , disease , physics , receptor , optics
Vaso-occlusive crisis (VOC) is one of the main causes of hospital admission in patients with sickle cell disease (SCD). Ketamine is often used as an adjuvant to opioids to control sickle cell crisis; however, there is a lack of evidence about its safety and efficacy for VOC in SCD patients.